Al-Barghouthy G - Search Results

1

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.

Smith LA, Jackson MJ, Al-Barghouthy G, Rose S, Kuoppamaki M, Olanow W, Jenner P. Smith LA, et al. Among authors: al barghouthy g. Mov Disord. 2005 Mar;20(3):306-14. doi: 10.1002/mds.20317. Mov Disord. 2005. PMID: 15490461

2

Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.

Kuoppamäki M, Al-Barghouthy G, Jackson M, Smith L, Zeng BY, Quinn N, Jenner P. Kuoppamäki M, et al. Among authors: al barghouthy g. Mov Disord. 2002 Nov;17(6):1312-7. doi: 10.1002/mds.10263. Mov Disord. 2002. PMID: 12465074

3

Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets.

Jackson MJ, Al-Barghouthy G, Pearce RK, Smith L, Hagan JJ, Jenner P. Jackson MJ, et al. Among authors: al barghouthy g. Pharmacol Biochem Behav. 2004 Nov;79(3):391-400. doi: 10.1016/j.pbb.2004.07.015. Pharmacol Biochem Behav. 2004. PMID: 15582011

4

Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.

Smith LA, Jackson MJ, Johnston L, Kuoppamaki M, Rose S, Al-Barghouthy G, Del Signore S, Jenner P. Smith LA, et al. Among authors: al barghouthy g. Clin Neuropharmacol. 2006 May-Jun;29(3):112-25. doi: 10.1097/01.WNF.0000220818.71231.DF. Clin Neuropharmacol. 2006. PMID: 16772809

5

Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.

Jackson MJ, Smith LA, Al-Barghouthy G, Rose S, Jenner P. Jackson MJ, et al. Among authors: al barghouthy g. Exp Neurol. 2007 Mar;204(1):162-70. doi: 10.1016/j.expneurol.2006.10.005. Epub 2006 Nov 16. Exp Neurol. 2007. PMID: 17113078

6

The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration.

Smith LA, Jackson MJ, Al-Barghouthy G, Jenner P. Smith LA, et al. Among authors: al barghouthy g. J Neural Transm (Vienna). 2002 Feb;109(2):123-40. doi: 10.1007/s007020200009. J Neural Transm (Vienna). 2002. PMID: 12075853

7

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates.

Kuoppamäki M, Al-Barghouthy G, Jackson MJ, Smith LA, Quinn N, Jenner P. Kuoppamäki M, et al. Among authors: al barghouthy g. J Neural Transm (Vienna). 2007 Sep;114(9):1147-53. doi: 10.1007/s00702-007-0727-3. Epub 2007 Apr 20. J Neural Transm (Vienna). 2007. PMID: 17446998

8

MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.

Zeng BY, Iravani MM, Lin ST, Irifune M, Kuoppamäki M, Al-Barghouthy G, Smith L, Jackson MJ, Rose S, Medhurst AD, Jenner P. Zeng BY, et al. Among authors: al barghouthy g. Eur J Neurosci. 2006 Apr;23(7):1766-74. doi: 10.1111/j.1460-9568.2006.04718.x. Eur J Neurosci. 2006. PMID: 16623833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters